Previous 10 | Next 10 |
AOTI Secures Major Expansion Funding from Leading Healthcare Financier PR Newswire OCEANSIDE, Calif. , March 25, 2022 /PRNewswire/ -- Advanced Oxygen Therapy Inc. (AOTI), the global leader in noninvasive topical oxygen wound healing solutions, announced t...
SWK Holdings to Participate in Maxim's 2022 Virtual Growth Conference PR Newswire DALLAS , March 23, 2022 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science focused specialty finance company catering to s...
Enteris BioPharma, a unit of SWK Holdings (NASDAQ:SWKH), announced the publication of a new white paper titled 'HPAPI Drug Solid Oral Dosage (SOD) Manufacturing – Ensuring Content Uniformity.' The paper, co-authored by Thomas Daggs, vice president of product development & quality c...
Enteris BioPharma Publishes White Paper on Best Practices for Ensuring Content Uniformity in Solid Oral Dosage Manufacturing with HPAPI Paper examines barriers to achieving optimal content uniformity with HPAPIs and the techniques manufacturers should use with low-dose drug prod...
Enteris BioPharma to Participate in DCAT® Week 2022 PR Newswire BOONTON, N.J. , March 2, 2022 /PRNewswire/ -- Enteris BioPharma, Inc. , a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a whol...
SWK Holdings Announces Reconstitution of Board of Directors with New Appointments PR Newswire DALLAS , Feb. 16, 2022 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life sciences focused specialty finance company catering to small- and mid-sized co...
Enteris BioPharma Highlights Progress in Oral Feasibility Program Six feasibility programs underway for oral tablet formulations developed with Enteris' Peptelligence® and ProPerma® technology platforms PR Newswire BOONTON, N.J. , Feb. 15, 2022 /PRN...
Investing in the biotech industry is an art, not a science. While the potential for gains from groundbreaking therapies exists, the majority fail. By utilizing statistics, careful selection, and net present value calculations, it is quite easy to find a basket that fulfills your p...
Enteris BioPharma Launches Enhanced Website Showcasing Full Suite of Bench to Market™ Services PR Newswire BOONTON, N.J. , Jan. 10, 2022 /PRNewswire/ -- Enteris BioPharma, Inc. , a biotechnology company developing innovative drug products based on its ...
Special Committee Concludes Review of Non-Binding Proposal from Carlson Capital PR Newswire DALLAS , Jan. 5, 2022 /PRNewswire/ --SWK Holdings Corporation (Nasdaq: SWKH) (the "Company" or "SWK") today announced that the special committee of the Company's board...
News, Short Squeeze, Breakout and More Instantly...
SWK Holdings Corporation Company Name:
SWKH Stock Symbol:
OTCMKTS Market:
SWK Holdings Corporation Website:
Company Also Promotes Controller DALLAS, TX / ACCESSWIRE / July 8, 2024 / SWK Holdings Corporation (Nasdaq:SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small- and mid-sized commercial-stage companies, is pleased to announce the appointment of ...
2024-06-24 21:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Conference Call and Live Audio Webcast Scheduled for Thursday, May 16, 2024, at 10:00 a.m. ET Corporate Highlights First quarter 2024 GAAP net income was $0.9 million, compared with net income of $4.6 million or $0.36 per share, for the first quarter 2023 First quarter 2024 finance r...